Notice ID: 2ca9ffd34e33499b83cfac3dfa72af6cSpecial Notice
NOTICE of Intent to SOLE SOURCE - DS Government Solutions
Active, responses due . Full description on SAM.gov.
Description
The vendor shall provide the license for the updated ABAQUS software. The vendor shall also provide technical support if/when needed throughout the year. If there are any issues with software the vendor shall provide fix. ABAQUS is approved in the CDC SRT tool.
Overview
Agency:
Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION
Office:CDC OFFICE OF ACQUISITION SERVICES
Posted:June 25, 2026
NAICS:541380: Testing Laboratories and Services
Last Updated:Oct 21, 2026
First published:
Last updated on SAM.gov:
PSC:Not specified
Set-Aside:Not specified
Type:Special Notice
Place of Performance:Atlanta, Georgia, 30341
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
Sole Source Justification Signed_Redacted.pdf
300 KBAdded in Special Notice version 1Posted
Lifecycle
- 1Version 1Special NoticeCurrent
NOTICE of Intent to SOLE SOURCE - DS Government Solutions
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
Attachment: Notice of Intent | Pre-Solicitation | 541380 | No Set-Aside | 10/15/2026 | 10/21/2026 | Bethesda, MD | |
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith the format in FAR Subpart 12.6, as supplemented with additional information includedin this notice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00007. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifapplicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to University of Alabama at Birmingham, 701 S 20th Street, Birmingham, AL 35294-0001-0001, for research support to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker of chlorine-induced acute lung injury, using the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, established mechanistic expertise, access to its actively enrolling aspiration pneumonitis biorepository (human proxy cohort), existing collaborative infrastructure with the NHLBI Laboratory of Precision Omics, and continuity with peer-reviewed federal funding (NIH R01 HL031197). These capabilities are not available from any other source and are essential to the project's feasibility. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv)The associated NAICS code is 541380, Testing Laboratories and Services, and the small business size standard is $19.0 million. This requirement is not set aside for small business. | Combined Synopsis | 541380 | No Set-Aside | 10/13/2026 | 10/23/2026 | - | |
Sources Sought: Provide blood and blood products to the Quentin N. Burdick Memorial Healthcare Facility (QNB) in Belcourt North Dakota. Sources Sought Notice Number: IHS-SS-26-1524548 This Sources Sought Notice is for informational and planning purposes only and shall not be construed as a solicitation, an obligation or commitment by the Indian Health Service. This notice is intended strictly for market research to determine the availability of small businesses. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. The anticipated applicable NAICS code for this acquisition is 541380, Testing Laboratories and Services- other relevant NAICS codes will be considered based on responses received (such as conference centers, etc.) 1.0 BACKGROUND The IHS is an agency within the Department of Health & Human Services and is responsible for providing federal health services to American Indians and Alaska Natives. The Indian Health Service provides a comprehensive health service delivery system for approximately 1.9 million American Indians and Alaska Natives who belong to 567 federally recognized tribes, in 35 states. The Indian Health Service Headquarters is located in Rockville, MD and then divided into twelve (12) physical areas: Alaska, Albuquerque, Bemidji, Billings, California, Great Plains, Nashville, Navajo, Oklahoma, Phoenix, Portland, and Tucson. The Great Plains Area Office (GPAO) works in conjunction with 19 Indian Health Service Units and Tribal Managed Service Units to provide health care to approximately 130,000 Native American located in North Dakota, South Dakota, Nebraska, and Iowa. QNBMHCF falls under the GPAO and provides medical care to approximately 14,550 tribal members living on the Turtle Mountain Indian Reservation. The Service Unit was built in 1967 with renovation and clinic expansion completed in 1992, to provide an expanded level of outpatient health care services specifically designed to meet the needs of our population. Services include: 24 Hour Emergency Services, Laboratory, Radiology (CAT Scan & Mobile MRI) and 24-Hour Pharmacy Services, Optometry, Dental, Clinic, Emergency, Podiatry, Same Day Clinic, and Behavioral Health. 2.0 SCOPE Provide QNB with blood and blood products. These products will be used to provide direct patient care in our ER, OR, and OB wards. This firm-fixed-price Purchase Order will be for one base year and 4 option years. Vendor will ship out new Red Blood Cell (RBC) stock every two to three weeks. Old stock will be shipped back to the vendor when new stock arrives. Plasma and Platelets will be sent on an as needed basis. Packed red blood cells will be automatically delivered every two to three weeks. 3.0 TYPE OF ORDER This is a firm fixed price purchase order. 4.0 ANTICIPATED PERIOD OF PERFORMANCE Period of Performance: Base + 4 option years 5.0 PLACE OF PERFORMANCE Quentin N Burdick Memorial Health Care Facility 1300 Hospital Loop Belcourt, ND 58316 6.0 REPORT(S)/DELIVERABLES AND DELIVERY SCHEDULE Delivery Location: Quentin N. Burdick Memorial Health Care Facility Belcourt, ND 58316 7.0 PAYMENT IPP Invoice clause: HHSAR 352.232-71 Electronic Submission of Invoice Payment Requests (Feb 2022) (a) Definitions. As used in this clause- Payment request means a bill, voucher, invoice, or request for contract financing payment with associated supporting documentation. The payment request must comply with the requirements identified in FAR 32.905(b), "Content of Invoices" and the applicable Payment clause included in this contract. (b) Except as provided in paragraph (c) of this clause, the Contractor shall submit payment requests electronically using the Department of Treasury Invoice Processing Platform (IPP) or successor system. Information regarding IPP, including IPP Customer Support contact information, is available at www.ipp.gov or any successor site. (c) The Contractor may submit payment requests using other than IPP only when the Contracting Officer authorizes alternate procedures in writing in accordance with HHS procedures. (d) If alternate payment procedures are authorized, the Contractor shall include a copy of the Contracting Officer's written authorization with each payment request. (END OF CLAUSE) Unless otherwise agreed to by the contracting officer per HHSAR 352.232-71(c), the use of IPP shall take precedence over previously established invoicing procedures." In compliance with the Office of Management and Budget (OMB) M-15-19 memorandum Improving Government Efficiency and Saving Taxpayer Dollars Through Electronic Invoicing directing Federal agencies to adopt electronic invoicing as the primary means to disburse payment to vendors. Invoices submitted under any award resulting from this solicitation will be required to utilize the Invoice Processing Platform (IPP) in accordance with HHSAR 352.232-71, Electronic Submission and Processing of Payment Requests IPP is a secure, web-based electronic invoicing system provided by the U.S. Department of the Treasurys Bureau of the Fiscal Service, in partnership with the Federal Reserve Bank of St. Louis (FRSTL). If your organization is already registered to use IPP, you will not be required to re-register- however, we encourage you make sure your organization and designated IPP user accounts are valid and up to date. The IPP website address is: https://www.ipp.gov If you require assistance registering or IPP account access, please contact the IPP Helpdesk at (866) 973-3131 (M-F 8AM to 6PM ET), or IPPCustomerSupport@fiscal.treasury.gov 8.0 Capability Statement/Information: Interested parties are expected to review this notice to familiarize themselves with the requirements of this project. Failure to do so will be at your firm’s own risk. The following information shall be included in the capability statement: 1. A general overview of the respondents’ opinions about the difficulty and/or feasibility of the potential requirement, and any information regarding innovative ideas or concepts. 2. Information in sufficient detail about the respondent’s (a) current capability and capacity to perform the work; (b) prior completed events of similar nature/size; (c) organizational experience and management capability; and (d) examples of prior completed Government contracts and other related information. 3. The respondents’ UEI number, organization name, address, point of contact, and size and type of business (e.g., 8(a), HUBZone, etc.) Pursuant to the North American Industry Classification System (NAICS) code: 541380, Testing Laboratories and Services, or comparable NAICS 4. Any other information that may be helpful in developing or finalizing the requirements of the potential acquisition. 5. The capability statement shall not exceed 10 single-sided pages (including all attachments, resumes, charts, etc.) presented in single-space and using a 12-point font size minimum, in either Microsoft Word or Adobe Portable Document Format (PDF), with 8-1/2 by 11-inch paper size, and 1 inch top, bottom, left and right margins. 6. All proprietary information should be marked as such. Statements should also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferably placed under the eligible small business concern’s name and address). Responses will be reviewed only by IHS personnel and will be held in a confidential manner. 9.0 Closing Statement Point of Contact: Jody Keplin, Purchasing Agent, at Jody.Keplin@ihs.gov Submission Instructions: Interested parties shall submit capability via email to Jody Keplin, at Jody.Keplin@ihs.gov . Must include Sources Sought Number IHS-SS-26-1524548 in the Subject line. The due date for receipt of statements is October 8, 2026 12:00 p.m. Central Time. All responses must be received by the specified due date and time in order to be considered. This notice is for information and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of IHS. IHS does not intend to award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted. As a result of this notice, IHS may issue a Request for Quote (RFQ). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claims against IHS shall arise as a result of a response to this notice or IHS’s use of such information as either part of our evaluation process or in developing specifications for any subsequent requirement. Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. | Market Research | 541380 | Total Small Business Set-Aside | 09/23/2026 | 10/08/2026 | Belcourt, ND | |
The Centers for Disease Control and Prevention (CDC) awarded a sole source contract with MATHEMATICA INC., 1100 1ST ST NE FL 12, WASHINGTON, DC. 20002 This notice is provided in accordance with RFO FAR 8.401 & GSAM/R 538.7104-3(b)(1) . Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases (DBD) requires support Services with the contractor listed above. The requested contractor Mathematica qualified as “innovator status” vendor for data analysis by Center for Medicare and Medicaid Services (CMS). Mathematica also has demonstrated experience and specialized staff with unique access and analytical capabilities for Medicaid data sets which captures the largest segment of US healthcare data, including births. The contractor shall perform analyses across four technical dimensions defined in the Statement of Work: (1) validating infant GBS case counts using TAF OT claims and evaluating a fourth case definition tied to maternal Medicaid IDs; (2) developing and refining a probabilistic mother-infant linkage algorithm using the Medicaid Case Number and supplementary variables; (3) estimating maternal vaccination coverage (COVID-19, influenza, Tdap, and prospectively RSV) accounting for bundled payment code effects; and (4) applying methods to reduce gestational age missingness using prenatal claims data. These tasks require continuity with linkage algorithms and case-definition logic Mathematica has already built and validated under prior CDC task orders. The authority permitting other than full and open competition is Title III of the Federal Property and Administrative Services Act of 1949 (41 U.S.C. 251, et seq.); Title 40 U.S.C. 501, Services for Executive Agencies, as implemented at FAR 8.401 and GSAM/R 538.7104-3(b)(1) "Only one source is capable of providing the products, services, or solution required at the level of quality required because the products, services, or solutions are unique or highly specialized." Through its prior contracts, Mathematica has already built key parts of this analysis—including updating the medical codes used to identify cases, working to link mother and infant records more completely, and adjusting for how individual states handle Medicaid enrollment for newborns. This steady, hands-on progress means Mathematica starts this next phase of work already ahead, with the knowledge and tools in place that a new contractor would not have. All responsible sources may submit a capability statement, proposal, or quotation to Robin C. Meyer, Contract Specialist, at rcm2@cdc.gov, which shall be considered by the agency. The deadline for submissions is Ocotber 31, 2026 at 4:30PM EST. The Government will review any/all information submitted to determine if other responsible sources exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement. | Special Notice | 541611 | No Set-Aside | 10/16/2026 | 10/31/2026 | - | |
PRESOLICITATION NOTICE Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA) This presolicitation notice is prepared in accordance with Revolutionary FAR Overhaul 5.101. 1. Points of Contact H. Taylor Wellman, Contract Specialist Office of Acquisition Services Centers for Disease Control and Prevention Chamblee Campus Building 108 4770 Buford Highway Atlanta, GA 30341 Email: xur0@cdc.gov H. Dale Bish, Contracting Officer Office of Acquisition Services Centers for Disease Control and Prevention Chamblee Campus Building 108 4770 Buford Highway Atlanta, GA 30341 Email: uwo8@cdc.gov 2. Set-Asides This acquisition is currently unrestricted. All responsible sources, including small businesses and other than small business concerns, are encouraged to respond. 3. Codes for Services or Supplies North American Industry Classification System (NAICS) Code: 541990 – All Other Professional, Scientific, and Technical Services Product Service Code (PSC): R499 – Support-Professional: Other 4. Description (i) The Centers for Disease Control and Prevention (CDC), on behalf of the National Institute for Occupational Safety and Health (NIOSH), intends to solicit offers for Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA). The anticipated contract will support NIOSH's Division of Compensation Analysis and Support (DCAS) in fulfilling its statutory obligations under EEOICPA by performing radiation dose reconstructions for claims referred by the Department of Labor (DOL) and evaluating petitions for additions of classes to the Special Exposure Cohort (SEC). The anticipated contract type is Cost Plus Award Fee (CPAF). The anticipated period of performance is March 1, 2027 through February 29, 2028 (base year), with four (4) twelve-month option periods through February 28, 2032. Work will be performed at the contractor's facility. The scope of work includes the following principal task areas: Identification of data relevant to reconstructing radiation doses and evaluating SEC petitions Claimant communications, including computer assisted telephone interviews Dose estimation and reporting Special Exposure Cohort petition evaluations Technical and program management support Operational continuity, cloud migration, and modernization of DCAS systems and processes Contractor personnel performing work under this contract will be required to obtain background investigations commensurate with a Level 5C Moderate Risk position sensitivity designation. Additionally, a reasonable number of contractor staff must possess or be able to obtain Department of Energy Q clearances to perform work under this contract. All contractor personnel must comply with applicable HHS and CDC information security policies. (ii) Not applicable. This acquisition is expected to exceed the simplified acquisition threshold. (iii) One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. (iv) All technical data required to respond will be provided as part of the solicitation. (v) Not applicable. This is not a construction contract. (vi) All responsible sources may submit a quotation, bid, or proposal, as appropriate, which will be considered by the agency. (vii) Not applicable. This acquisition is competitive. (viii) Contractor personnel performing work under this contract will be required to obtain background investigations commensurate with a Level 5C Moderate Risk position sensitivity designation. Additionally, a reasonable number of contractor staff must possess or be able to obtain Department of Energy Q clearances. Additional information regarding security requirements will be provided as part of the solicitation. Timing There is no solicitation available at this time. A solicitation is anticipated to be issued in November 2026. | Pre-Solicitation | 541990 | No Set-Aside | 10/14/2026 | 10/30/2026 | Atlanta, GA |
Additional Details
Solicitation Number
98071
Archive Date
Aug 4, 2027
Office Address
ATLANTA, GA, 30333